Literature DB >> 4852534

Intracellular bactericidal effects of rifampicin in both normal and chronic ganulomatous disease polymorphs.

G Ezer, J F Soothill.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4852534      PMCID: PMC1648774          DOI: 10.1136/adc.49.6.463

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  16 in total

1.  A syndrome of recurrent infection and infiltration of viscera by pigmented lipid histiocytes.

Authors:  B H LANDING; H S SHIRKEY
Journal:  Pediatrics       Date:  1957-09       Impact factor: 7.124

2.  Effect of tetracycline, polymyxin B, and rifampin on phagocytosis.

Authors:  P D Hoeprich; C H Martin
Journal:  Clin Pharmacol Ther       Date:  1970 May-Jun       Impact factor: 6.875

3.  Comparison of the antibacterial activity of rifampicin and other antibiotics.

Authors:  W R McCabe; V Lorian
Journal:  Am J Med Sci       Date:  1968-10       Impact factor: 2.378

4.  Three cases of meningococcal infection in a family, associated with a deficient immune response.

Authors:  D M Jones; B M Tobin; A Butterworth
Journal:  Arch Dis Child       Date:  1973-09       Impact factor: 3.791

5.  Effect of antibiotics on the bactericidal activity of human leukocytes.

Authors:  J W Alexander; R A Good
Journal:  J Lab Clin Med       Date:  1968-06

6.  Studies of polymorphonuclear leukocytes from patients with chronic granulomatous disease of childhood: bactericidal capacity for streptococci.

Authors:  E L Kaplan; T Laxdal; P G Quie
Journal:  Pediatrics       Date:  1968-03       Impact factor: 7.124

7.  Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies.

Authors:  G L Mandell; T K Vest
Journal:  J Infect Dis       Date:  1972-05       Impact factor: 5.226

8.  Bactericidal activity of polymorphonuclear leukocytes from patients with severe bacterial infections.

Authors:  J L Copeland; L R Karrh; J McCoy; J C Guckian
Journal:  Tex Rep Biol Med       Date:  1971

9.  Protection of phagocytized bacteria from the killing action of antibiotics.

Authors:  B Holmes; P G Quie; D B Windhorst; B Pollara; R A Good
Journal:  Nature       Date:  1966-06-11       Impact factor: 49.962

10.  In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood.

Authors:  P G Quie; J G White; B Holmes; R A Good
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

View more
  6 in total

1.  Protection of staphylococci ingested by macrophages from the bactericidal action of rifampin.

Authors:  E L Pesanti
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

2.  Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity.

Authors:  W L Hand; N L King-Thompson
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

3.  The management of chronic granulomatous disease.

Authors:  A Fischer; A W Segal; R Seger; R S Weening
Journal:  Eur J Pediatr       Date:  1993-11       Impact factor: 3.183

4.  Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections.

Authors:  P Van der Auwera; J Klastersky; J P Thys; F Meunier-Carpentier; J C Legrand
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

5.  Membrane transport of clindamycin in alveolar macrophages.

Authors:  W L Hand; N L King-Thompson
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

6.  Chronic granulomatous disease in an adult.

Authors:  D A Burns; I Sarkany
Journal:  J R Soc Med       Date:  1979-02       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.